                         SEQUENCE LISTING

<110>  Second Genome, Inc.
 
<120>  GEMELLA SANGUINIS AS A BIOTHERAPEUTICS

<130>  SEGE-020/01WO 321077-2040

<150>  US 62/563,124
<151>  2017-09-26

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  1510
<212>  DNA
<213>  Gemella sanguinis

<400>  1
gacgaacgct ggcggcgtgc ctaatacatg caagtcgagc gaagtttttc tggtgcttgc       60

actagaaaaa cttagcggcg aacgggtgag taacacgtaa agaacctgcc tcatagacgg      120

ggacaactat tggaaacgat agctaatacc ggataacagc ataaatcgca tgatatatgt      180

ttaaaagttg gtttcggcta acactatgag atggctttgc ggtgcattag ctagttggtg      240

gggtaaaggc ctaccaaggc gacgatgcat agccgacctg agagggtgat cggccacact      300

gggactgaga cacggcccag actcctacgg gaggcagcag tagggaatct tccgcaatgg      360

gcgaaagcct gacggagcaa cgccgcgtga gtgaagaagg atttcggttc gtaaagctct      420

gttgttaggg aagaatgatt gtatagtaac tatatacagt agagacggta cctaaccaga      480

aagccacggc taactacgtg ccagcagccg cggtaatacg taggtggcaa gcgttgtccg      540

gaattattgg gcgtaaagcg cgcgcaggtg gtttaataag tctgatgtga aagcccacgg      600

ctcaaccgtg gagggtcatt ggaaactgtt aaacttgagt gcaggagaga aaagtggaat      660

tcctagtgta gcggtgaaat gcgtagagat taggaggaac accagtggcg aaggcggctt      720

tttggcctgt aactgacact gaggcgcgaa agcgtgggga gcaaacagga ttagataccc      780

tggtagtcca cgccgtaaac gatgagtgct aagtgttggt ctcataagag atcagtgctg      840

cagctaacgc attaagcact ccgcctgggg agtacgaccg caaggttgaa actcaaagga      900

attgacgggg acccgcacaa gcggtggagc atgtggttta attcgaagca acgcgaagaa      960

ccttaccaag tcttgacata ctgtgaggac acaagagatt gtgttgttct gacctttggt     1020

tagacacaga tacaggtggt gcatggttgt cgtcagctcg tgtcgtgaga tgttgggtta     1080

agtcccgcaa cgagcgcaac ccctatgtct agttgccagc agtaagatgg ggactctaga     1140

cagactgcca gtgataaact ggaggaaggc ggggatgacg tcaaatcatc atgcccctta     1200

tgacttgggc tacacacgtg ctacaatgga taggaacaaa gagaagcaaa ctcgcgagag     1260

caagcaaacc tcataaaact attctcagtt cggattgtag tctgcaactc gactacatga     1320

agctggaatc gctagtaatc gcgaatcaga atgtcgcggt gaatacgttc ccgggtcttg     1380

tacacaccgc ccgtcacacc acgagagttt gtaacacccg aagacggtgg cctaaccttt     1440

aaggagggag ccggtcacgg tgggacagat gattggggtg aagtcgtaac aaggtagccg     1500

tatcggaagg                                                            1510


